Health Catalyst (HCAT) Research & Development (2018 - 2026)

Health Catalyst's Research & Development history runs 9 years deep, the most recent figure standing at $10.6 million for Q1 2026.

• Quarterly Research & Development fell 28.18% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.2 million (down 14.45% YoY) and the FY2025 annual result came in at $52.5 million, down 3.51% from the prior year.
• Research & Development was $10.6 million for Q1 2026 at Health Catalyst, up from $10.2 million in the prior quarter.
• Across five years, Research & Development topped out at $31.4 million in Q4 2022 and bottomed at $10.2 million in Q4 2025.
• A 5-year average of $16.5 million and a median of $14.9 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development surged 43.84% — and 2024, when it slumped 50.21%.
• Health Catalyst's Research & Development stood at $31.4 million in 2022, then decreased by 28.21% to $22.6 million in 2023, then slumped by 50.21% to $11.2 million in 2024, then retreated by 9.52% to $10.2 million in 2025, then rose by 4.06% to $10.6 million in 2026.
• Business Quant data shows HCAT's Research & Development at $10.6 million in Q1 2026, $10.2 million in Q4 2025, and $12.3 million in Q3 2025.